{"id":"rbc","safety":{"commonSideEffects":[{"rate":"null","effect":"Allergic reaction"},{"rate":"null","effect":"Infection"},{"rate":"null","effect":"Iron overload"}]},"_chembl":{"chemblId":"CHEMBL6011678","moleculeType":null,"molecularWeight":"301.33"},"_dailymed":{"setId":"4a318b8e-e2fc-454c-bc4c-0bbc1816ce8a","title":"RBC (IRON, CINCHONA BARK, POTASSIUM CARBONATE, SODIUM CHLORIDE, TRIBASIC CALCIUM PHOSPHATE, SOLIDAGO VIRGAUREA FLOWERING TOP) LIQUID [GROUPE CYRENNE INC.]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Red blood cells carry oxygen throughout the body, and transfusions are used to treat conditions such as anemia or blood loss due to injury or surgery.","oneSentence":"Red blood cell transfusion is used to increase the number of red blood cells in the body.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T05:25:43.787Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anemia due to chronic kidney disease"},{"name":"Anemia due to chemotherapy"},{"name":"Anemia due to HIV infection"}]},"trialDetails":[{"nctId":"NCT00007150","phase":"PHASE2","title":"Treatment of Hemochromatosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2001-01-01","conditions":"Hemochromatosis","enrollment":622},{"nctId":"NCT04404881","phase":"PHASE2","title":"Bevacizumab In Hereditary Hemorrhagic Telangiectasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hanny Al-Samkari, MD","startDate":"2020-11-23","conditions":"Hereditary Hemorrhagic Telangiectasia","enrollment":33},{"nctId":"NCT06439082","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-10-24","conditions":"Sickle Cell Disease","enrollment":315},{"nctId":"NCT07492589","phase":"PHASE2","title":"Photo-Acoustic and Ultrasonographic Mammoscope","status":"RECRUITING","sponsor":"Franciscus Gasthuis & Vlietland (Hospital)","startDate":"2026-02-01","conditions":"Benign Breast Lesions, Malignant Breast Tumours","enrollment":180},{"nctId":"NCT03842189","phase":"PHASE2","title":"A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-04-05","conditions":"Hemolytic Disease of the Fetus and Newborn","enrollment":25},{"nctId":"NCT01572506","phase":"PHASE1","title":"Mechanisms Accounting for Unexplained Anemia in the Elderly","status":"COMPLETED","sponsor":"National Institute on Aging (NIA)","startDate":"2012-03-29","conditions":"Anemia","enrollment":58},{"nctId":"NCT05664737","phase":"PHASE2","title":"A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2022-12-09","conditions":"Anemia","enrollment":189},{"nctId":"NCT03910452","phase":"EARLY_PHASE1","title":"Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-10-28","conditions":"Chronic Granulomatous Disease","enrollment":4},{"nctId":"NCT07231471","phase":"NA","title":"Platelet Rich Plasma for Musculoskeletal Conditions","status":"RECRUITING","sponsor":"University of Utah","startDate":"2025-12-29","conditions":"Osteoarthritis (OA), Osteoarthritis (OA) of the Knee, Osteoarthritis (OA) of the Hip","enrollment":10000},{"nctId":"NCT07096297","phase":"PHASE2","title":"Luspatercept + Darbepoetin in MDS","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-12-16","conditions":"MDS (Myelodysplastic Syndrome)","enrollment":60},{"nctId":"NCT03889834","phase":"NA","title":"Biological Parameters Changes After Autologous Blood Transfusion of Red Blood Cells (200 ml) in Healthy Volunteers.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-01-25","conditions":"The Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy Volunteers","enrollment":30},{"nctId":"NCT03037164","phase":"PHASE3","title":"INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cerus Corporation","startDate":"2017-05-11","conditions":"Anemia","enrollment":692},{"nctId":"NCT01282021","phase":"","title":"Molecular Immunohematology in Ethiopian Sub-Populations","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2012-11-03","conditions":"Immunohematology","enrollment":95},{"nctId":"NCT07486531","phase":"","title":"Iron Accumulation in Erythrocytes in Patients","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-10-20","conditions":"Beta Thalassemia Major","enrollment":100},{"nctId":"NCT06399822","phase":"NA","title":"Impact of Capillaroscopy on the Management of Undifferentiated Connective Tissue Disease","status":"RECRUITING","sponsor":"CHU de Quebec-Universite Laval","startDate":"2024-05-22","conditions":"Undifferentiated Connective Tissue Diseases","enrollment":40},{"nctId":"NCT07187401","phase":"PHASE1, PHASE2","title":"A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2026-02-11","conditions":"Paroxysmal Nocturnal Hemoglobinuria (PNH), Persistent Anemia","enrollment":24},{"nctId":"NCT06839326","phase":"NA","title":"Efficacy of Autologous Conditioned Serum in Temporomandibular Joint Disorder","status":"COMPLETED","sponsor":"Batman University","startDate":"2024-11-01","conditions":"Temporomandibular Joint Osteoarthritis","enrollment":75},{"nctId":"NCT06331364","phase":"NA","title":"TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): a Stepped-Wedge Cluster Randomized Trial","status":"RECRUITING","sponsor":"Duke University","startDate":"2026-02-27","conditions":"Lower Resp Tract Infection","enrollment":765},{"nctId":"NCT03685721","phase":"","title":"Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease","status":"RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2018-10-11","conditions":"Sickle Cell, PKLR Variants, Adenosine Triphosphate Activities","enrollment":800},{"nctId":"NCT03878706","phase":"","title":"The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination","status":"RECRUITING","sponsor":"University of Athens","startDate":"2017-11-03","conditions":"Diabetes Mellitus, Type 2","enrollment":240},{"nctId":"NCT06872333","phase":"PHASE2","title":"Allo HSCT for High Risk Hemoglobinopathies","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-11-19","conditions":"Graft Failure, Sickle Cell Disease, Hemoglobinopathies","enrollment":62},{"nctId":"NCT06840756","phase":"PHASE4","title":"Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes","status":"RECRUITING","sponsor":"Michelle Zeller","startDate":"2025-09-11","conditions":"Red Blood Cell Transfusions, Sex Differences, Health Services","enrollment":11082},{"nctId":"NCT06734611","phase":"NA","title":"Folic Acid Salt Study (FISFA Zambia)","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-05-01","conditions":"Folate Deficiency, Neural Tube Defects","enrollment":250},{"nctId":"NCT07465029","phase":"","title":"A Study of Incidence, Treatment Patterns, and Outcomes in Transfusion-dependent Lower-risk Myelodysplastic Syndromes in Spain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2026-02-02","conditions":"Lower-risk Myelodysplastic Syndromes (TD LR-MDS)","enrollment":1300},{"nctId":"NCT05357560","phase":"PHASE1","title":"A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2023-07-10","conditions":"Malaria, Plasmodium Falciparum","enrollment":107},{"nctId":"NCT07422480","phase":"PHASE3","title":"A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions","status":"RECRUITING","sponsor":"Takeda","startDate":"2026-04-01","conditions":"Myelodysplastic Syndrome, Anemia","enrollment":300},{"nctId":"NCT00542230","phase":"","title":"Blood Sampling for Research Related to Sickle Cell Disease","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2007-11-07","conditions":"Sickle Cell Trait, Sickle Cell Disease, Sickle Cell Anemia","enrollment":250},{"nctId":"NCT04040023","phase":"NA","title":"Patient Blood Management in Cardiac Surgery","status":"COMPLETED","sponsor":"Clinique Pasteur","startDate":"2019-09-10","conditions":"Surgical Blood Loss","enrollment":900},{"nctId":"NCT06607003","phase":"PHASE1","title":"Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-11-26","conditions":"Malaria","enrollment":300},{"nctId":"NCT04084080","phase":"PHASE3","title":"Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2020-02-26","conditions":"Sickle Cell Disease","enrollment":173},{"nctId":"NCT06875947","phase":"NA","title":"EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fakultas Kedokteran Universitas Padjadjaran","startDate":"2025-05-23","conditions":"Iron Deficiency Anemia of Pregnancy, Pregnancy Complications, Inflammation","enrollment":59},{"nctId":"NCT07446647","phase":"PHASE1","title":"Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion","status":"NOT_YET_RECRUITING","sponsor":"Jose Cancelas","startDate":"2026-03","conditions":"Healthy Volunteer Red Blood Cell Labeling Study; Not Disease Focused","enrollment":20},{"nctId":"NCT07439601","phase":"NA","title":"Long-Term Omega-3 and Omega-3 Index >8%: Effects on Physiological Recovery","status":"NOT_YET_RECRUITING","sponsor":"St. Mary's University, Twickenham","startDate":"2026-02-28","conditions":"Focus on Omega 3 Index on Recovery","enrollment":46},{"nctId":"NCT04171635","phase":"","title":"Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2019-12-16","conditions":"MRI Scans","enrollment":55},{"nctId":"NCT06078696","phase":"PHASE1, PHASE2","title":"Siplizumab for Sickle Cell Disease Transplant","status":"TERMINATED","sponsor":"Columbia University","startDate":"2023-09-28","conditions":"Anemia, Sickle Cell","enrollment":1},{"nctId":"NCT07436767","phase":"NA","title":"Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Sickle Cell Disease","enrollment":3},{"nctId":"NCT06664853","phase":"PHASE3","title":"Open-Label Extension of EryDex Study IEDAT-04-2022","status":"TERMINATED","sponsor":"Quince Therapeutics S.p.A.","startDate":"2024-12-11","conditions":"Ataxia Telangiectasia","enrollment":101},{"nctId":"NCT06543368","phase":"NA","title":"Low-Cost Platelet-Rich Plasma for Hemarthropathy","status":"COMPLETED","sponsor":"University of Utah","startDate":"2024-07-23","conditions":"Hemarthrosis, Hemophilia","enrollment":14},{"nctId":"NCT07271758","phase":"NA","title":"PROmega Pilot Study of Clinic-based DHA Blood Screening in Early Pregnancy","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-05","conditions":"Nutrient Deficiency","enrollment":650},{"nctId":"NCT06313398","phase":"EARLY_PHASE1","title":"Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling","status":"RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2024-05-17","conditions":"Sickle Cell Disease, Thalassemia, Hemoglobinopathy","enrollment":100},{"nctId":"NCT05615740","phase":"NA","title":"Prevention of Onset and Transition to an Advanced Form of Diabetic Retinopathy in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital Ostrava","startDate":"2022-05-02","conditions":"Diabetic Retinopathy","enrollment":187},{"nctId":"NCT06979492","phase":"PHASE4","title":"Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease","status":"RECRUITING","sponsor":"Emory University","startDate":"2026-04","conditions":"Sickle Cell Disease, Pregnancy Related","enrollment":50},{"nctId":"NCT06602804","phase":"NA","title":"Trima Non-DEHP Leukoreduced Red Blood Cell In Vivo Recovery Study","status":"COMPLETED","sponsor":"Terumo BCT","startDate":"2024-08-26","conditions":"Device Validation of In-vivo Performance","enrollment":37},{"nctId":"NCT07416045","phase":"","title":"A Multi-dimensional Evaluation of the Effects of Linear Accelerator X-ray Irradiation on Red Blood Cells","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-01-28","conditions":"Erythrocyte Destruction","enrollment":20},{"nctId":"NCT07341139","phase":"","title":"Blood Storage Related Mortality and Adverse Effects in Trauma Patients","status":"RECRUITING","sponsor":"Kocaeli City Hospital","startDate":"2026-01-17","conditions":"Transfusion Adverse Reaction, Major Trauma, Blood Product Transfusion for All Conditions","enrollment":300},{"nctId":"NCT04610866","phase":"PHASE1, PHASE2","title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2020-12-09","conditions":"Sickle Cell Disease, Hemolytic Anemia","enrollment":15},{"nctId":"NCT06710418","phase":"NA","title":"Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-10-15","conditions":"Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma","enrollment":50},{"nctId":"NCT06168266","phase":"NA","title":"Effects of Eccentric Exercise Training in Patients With COPD","status":"RECRUITING","sponsor":"Fu Jen Catholic University","startDate":"2023-12-13","conditions":"COPD","enrollment":170},{"nctId":"NCT07328191","phase":"NA","title":"Quality of Life-Guided Transfusion in Refractory MDS or AML","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2026-02-09","conditions":"MDS, AML, Adult, Anemia","enrollment":52},{"nctId":"NCT04423367","phase":"PHASE2","title":"Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment","status":"COMPLETED","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2020-09-13","conditions":"Acquired Pure Red Cell Aplasia","enrollment":18},{"nctId":"NCT06909487","phase":"","title":"Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respect to HAS 2014 Recommendations","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2025-03-25","conditions":"Very Preterm and Extremely Preterm Birth, Anemia, Erythrocyte Transfusion","enrollment":201},{"nctId":"NCT07402005","phase":"","title":"The Correlation of Lewis Antigens With VTE","status":"NOT_YET_RECRUITING","sponsor":"Larissa University Hospital","startDate":"2026-01-19","conditions":"Thromboembolic Disease","enrollment":200},{"nctId":"NCT05582447","phase":"","title":"Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2018-04-17","conditions":"Cholestasis, Red Cell Membrane and Enzyme Abnormalities","enrollment":40},{"nctId":"NCT02741648","phase":"","title":"RBC Irradiation, Anemia and Gut Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2016-07","conditions":"Anemia, Necrotizing Enterocolitis","enrollment":324},{"nctId":"NCT04419649","phase":"PHASE2","title":"A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)","status":"RECRUITING","sponsor":"Takeda","startDate":"2020-08-19","conditions":"Myelodysplastic Syndromes, Cytopenia","enrollment":160},{"nctId":"NCT05037760","phase":"PHASE2","title":"A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis","status":"RECRUITING","sponsor":"Takeda","startDate":"2021-12-16","conditions":"Myelofibrosis","enrollment":135},{"nctId":"NCT07380477","phase":"","title":"VentricuLostomy AssoCiaTed InfeCtions (LACTIC): Focus on CSF Lactate and Sampling Site","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2025-01-15","conditions":"Acute Brain Injury, Hydrocephalus, External Ventricular Drain","enrollment":148},{"nctId":"NCT07377851","phase":"NA","title":"Carbonic Anhydrase II Responses to Basketball-Specific High-Intensity Interval Training","status":"COMPLETED","sponsor":"Karamanoğlu Mehmetbey University","startDate":"2025-11-01","conditions":"Metabolic Adaptation to High-Intensity Interval Training","enrollment":24},{"nctId":"NCT03814746","phase":"PHASE3","title":"Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2019-07-26","conditions":"Sickle Cell Disease (SCD)","enrollment":255},{"nctId":"NCT05612919","phase":"NA","title":"Red Blood Cells From Umbilical Cord for Transfusion of Preterm Infants","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2023-09-13","conditions":"Infant, Extremely Premature, Erythrocyte Transfusion, Umbilical Cord Issue","enrollment":41},{"nctId":"NCT04431999","phase":"PHASE3","title":"Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage","status":"COMPLETED","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2021-12-04","conditions":"Trauma, Acute Hemorrhage, Coagulopathy","enrollment":200},{"nctId":"NCT04294641","phase":"PHASE2","title":"Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2021-05-10","conditions":"Chronic GVHD","enrollment":10},{"nctId":"NCT06142747","phase":"","title":"Tracking of Red Blood Cells Using Super Resolution Ultrasound in Persons With Healthy or Overuse Injured Tendons","status":"RECRUITING","sponsor":"University Hospital Bispebjerg and Frederiksberg","startDate":"2024-02-08","conditions":"Tendinopathy","enrollment":135},{"nctId":"NCT01565434","phase":"NA","title":"Erythrocyte Complement Receptor 1 and Alzheimer Disease","status":"COMPLETED","sponsor":"CHU de Reims","startDate":"2012-02","conditions":"Alzheimer Disease","enrollment":200},{"nctId":"NCT07346976","phase":"NA","title":"Investigation Into the Dynamic Variations of End-Tidal Carbon Monoxide Concentration (ETCOc) in Neonates Utilizing Non-Dispersive Infrared Spectroscopy and Its Implications for Jaundice Management","status":"RECRUITING","sponsor":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","startDate":"2025-12-05","conditions":"Neonatal Hyperbilirubinemia","enrollment":100},{"nctId":"NCT07341048","phase":"NA","title":"Potential Biological and Physiological Determinants for Exercice in Patients With Polycythemia Vera","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2026-01","conditions":"Polycythemia, Polycythemia Vera (PV)","enrollment":54},{"nctId":"NCT06944067","phase":"","title":"Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease","status":"RECRUITING","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2025-06-24","conditions":"Sickle Cell Disease","enrollment":50},{"nctId":"NCT06193200","phase":"PHASE3","title":"Evaluate the Neurological Effects of EryDex on Subjects With A-T","status":"COMPLETED","sponsor":"Quince Therapeutics S.p.A.","startDate":"2024-06-24","conditions":"Ataxia Telangiectasia","enrollment":105},{"nctId":"NCT07329530","phase":"NA","title":"Metabolic and Muscle Profile in ICU Survivors","status":"RECRUITING","sponsor":"Anne-Françoise Rousseau","startDate":"2025-12-01","conditions":"Critical Illness, Major Abdominal Surgeries","enrollment":100},{"nctId":"NCT05071079","phase":"NA","title":"A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2022-05-23","conditions":"Plasmodium Vivax Infection","enrollment":48},{"nctId":"NCT04591574","phase":"NA","title":"ABC - A Post Intensive Care Anaemia Management Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Edinburgh","startDate":"2020-09-01","conditions":"Anemia Acute, Fatigue, Physical Disability","enrollment":346},{"nctId":"NCT07326670","phase":"","title":"Effects of Spinal vs General Anesthesia on Systemic Inflammation in PCNL","status":"RECRUITING","sponsor":"Elazıg Fethi Sekin Sehir Hastanesi","startDate":"2025-10-15","conditions":"Anesthesia Techniques, Percutaneous Nephrolithotomy, Systemic Inflammation","enrollment":90},{"nctId":"NCT05100342","phase":"","title":"Prospective Validation of a Points Score System Predicting 30-day Survival","status":"RECRUITING","sponsor":"Indiana University","startDate":"2022-09-12","conditions":"Metastatic Cancer","enrollment":114},{"nctId":"NCT01174108","phase":"PHASE2","title":"Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells","status":"RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2010-12-10","conditions":"Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome)","enrollment":120},{"nctId":"NCT05545930","phase":"NA","title":"Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)","status":"RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2022-09-20","conditions":"Blood Recovery","enrollment":20},{"nctId":"NCT06721455","phase":"","title":"Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2025-08-01","conditions":"Heart Surgery, Blood Transfusion, Hemolysis","enrollment":50},{"nctId":"NCT06743113","phase":"NA","title":"Hypoxic Red Blood Cells in Sickle Cell Anemia","status":"NOT_YET_RECRUITING","sponsor":"Hemanext","startDate":"2026-03","conditions":"Sickle Cell Anaemia, Sickle Cell Anemia Crisis, Sickle Cell Anemia in Children","enrollment":48},{"nctId":"NCT06685848","phase":"NA","title":"Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion","status":"RECRUITING","sponsor":"Hemanext","startDate":"2024-11-29","conditions":"Hematologic Neoplasms","enrollment":24},{"nctId":"NCT05451940","phase":"PHASE1, PHASE2","title":"Hydroxyurea and EPO in Sickle Cell Disease","status":"COMPLETED","sponsor":"Julia Xu","startDate":"2023-05-25","conditions":"Anemia, Sickle Cell, Sickle Cell Disease","enrollment":17},{"nctId":"NCT04143724","phase":"PHASE2","title":"Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia","status":"RECRUITING","sponsor":"Celgene","startDate":"2019-11-07","conditions":"Beta-Thalassemia","enrollment":99},{"nctId":"NCT07320391","phase":"NA","title":"Ozonated Gel and Titanium Platelet-rich Fibrin (on Palatal Wound Healing","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-05-01","conditions":"Palatal Lesion","enrollment":39},{"nctId":"NCT07092683","phase":"","title":"Mediation Analysis in Cardiac Surgery","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-01","conditions":"Anemia, Cardiac Surgery, Transfusion","enrollment":13683},{"nctId":"NCT07313878","phase":"NA","title":"Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy","status":"RECRUITING","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2025-11-19","conditions":"Acute Lymphoblastic Leukaemias (ALL), Long Term Follow-Up","enrollment":30},{"nctId":"NCT05470816","phase":"PHASE3","title":"Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayside Health","startDate":"2022-11-01","conditions":"Surgical Site Infection, Dementia, Cognition","enrollment":826},{"nctId":"NCT06060639","phase":"NA","title":"Variation of Echocardiographic Parameters After Red Blood Cell Transfusion in Emergency Department Anemic Patients","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2023-11-09","conditions":"Anemia, Age Problem, Ultrasonography","enrollment":116},{"nctId":"NCT07307872","phase":"","title":"A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease","status":"COMPLETED","sponsor":"Amoneta Diagnostics SAS","startDate":"2017-03-23","conditions":"Alzheimer's Disease (AD), Neurodegenerative Disease, Dementia","enrollment":150},{"nctId":"NCT07262086","phase":"NA","title":"Clinical Evaluation of Wear Resistance and Bioactivity of Self Cured Bioactive Resin Composite","status":"ENROLLING_BY_INVITATION","sponsor":"Suez Canal University","startDate":"2025-11-22","conditions":"Dental Caries, Class II Dental Caries","enrollment":25},{"nctId":"NCT06457295","phase":"","title":"Impact of Diabetes Mellitus on Retinal Microvasculature in Patients Without Clinical Retinopathy Using Optical Coherence Tomography Angiography","status":"COMPLETED","sponsor":"Sohag University","startDate":"2024-12-20","conditions":"Diabetic Retinopathy, DR","enrollment":200},{"nctId":"NCT02352181","phase":"NA","title":"Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2014-12","conditions":"Liver Transplantation","enrollment":82},{"nctId":"NCT04983654","phase":"NA","title":"Functional and Mechanistic Characterization of Limb Ulcers in Patients With Sickle Cell Disease","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2022-02-09","conditions":"Ulcer, Anemia, Sickle Cell Disease","enrollment":70},{"nctId":"NCT07055503","phase":"","title":"Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients","status":"ENROLLING_BY_INVITATION","sponsor":"University Research Institute for the Study of Genetic & Malignant Disorders in Childhood","startDate":"2025-11-20","conditions":"Transfusion-dependent Beta-Thalassemia, Blood Transfusion","enrollment":30},{"nctId":"NCT07287371","phase":"PHASE4","title":"Sucrosomial Vs Intravenous Iron for Preoperative Anemia","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2025-12-31","conditions":"Anemia, Iron Deficiency Anemia","enrollment":75},{"nctId":"NCT05348915","phase":"PHASE3","title":"A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease","status":"TERMINATED","sponsor":"Pfizer","startDate":"2022-03-29","conditions":"Sickle Cell Disease, Vaso-occlusive Crisis, Vaso-occlusive Pain Episode in Sickle Cell Disease","enrollment":242},{"nctId":"NCT04987489","phase":"PHASE2","title":"A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease","status":"COMPLETED","sponsor":"Forma Therapeutics, Inc.","startDate":"2022-03-28","conditions":"Sickle Cell Disease, Thalassemia","enrollment":53},{"nctId":"NCT02750150","phase":"PHASE3","title":"Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2013-07-09","conditions":"Trauma, Coagulopathy","enrollment":42},{"nctId":"NCT07121140","phase":"NA","title":"Home Blood Transfusions","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2025-06-03","conditions":"Hematologic Malignancy, Myelodysplastic Syndromes, Acute Myeloid Leukemia","enrollment":30},{"nctId":"NCT04137692","phase":"NA","title":"Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome","status":"SUSPENDED","sponsor":"Weill Medical College of Cornell University","startDate":"2027-09","conditions":"Glucose Transporter Type 1 Deficiency Syndrome, GLUT1DS1","enrollment":12},{"nctId":"NCT05979207","phase":"PHASE1","title":"Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum","status":"COMPLETED","sponsor":"Medicines for Malaria Venture","startDate":"2023-08-01","conditions":"Infections, Vector Borne Diseases, Systemic Inflammatory Response Syndrome","enrollment":12},{"nctId":"NCT06485960","phase":"","title":"Validation of the Experience Sampling Dietary Assessment Method","status":"RECRUITING","sponsor":"KU Leuven","startDate":"2025-10-09","conditions":"Validation Study","enrollment":115},{"nctId":"NCT06285604","phase":"","title":"Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2024-09-10","conditions":"Neonatal Anemia","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20140909","type":"SUPPL","sponsor":"CURIUM","applicationNumber":"NDA019981"},{"date":"20000418","type":"SUPPL","sponsor":"CURIUM","applicationNumber":"NDA019981"},{"date":"19980123","type":"SUPPL","sponsor":"CURIUM","applicationNumber":"NDA019981"},{"date":"19920825","type":"SUPPL","sponsor":"CURIUM","applicationNumber":"NDA019981"},{"date":"19980408","type":"SUPPL","sponsor":"CURIUM","applicationNumber":"NDA019981"},{"date":"19910610","type":"ORIG","sponsor":"CURIUM","applicationNumber":"NDA019981"},{"date":"19930930","type":"SUPPL","sponsor":"CURIUM","applicationNumber":"NDA019981"}],"publicationCount":33363,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"RBC","genericName":"RBC","companyName":"Asan Medical Center","companyId":"asan-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Red blood cell transfusion is used to increase the number of red blood cells in the body. Used for Anemia due to chronic kidney disease, Anemia due to chemotherapy, Anemia due to HIV infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}